Clinical Trial Detail

NCT ID NCT02173093
Title Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Barbara Ann Karmanos Cancer Institute
Indications

melanoma

neuroblastoma

osteosarcoma

Ewing sarcoma

sarcoma

Advanced Solid Tumor

Therapies

Aldesleukin + GD2Bi-a ATC + Sargramostim

Age Groups: adult child

No variant requirements are available.